Oncotelic Therapeutics Stock Net Income
| OTLCDelisted Stock | USD 0.02 0 6.38% |
Oncotelic Therapeutics fundamentals help investors to digest information that contributes to Oncotelic Therapeutics' financial success or failures. It also enables traders to predict the movement of Oncotelic OTC Stock. The fundamental analysis module provides a way to measure Oncotelic Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oncotelic Therapeutics otc stock.
Oncotelic |
Oncotelic Therapeutics OTC Stock Net Income Analysis
Oncotelic Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Oncotelic Therapeutics Net Income | (9.39 M) |
Most of Oncotelic Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncotelic Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Oncotelic Therapeutics reported net income of (9.39 Million). This is 102.75% lower than that of the Healthcare sector and 113.41% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.64% higher than that of the company.
Oncotelic Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oncotelic Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Oncotelic Therapeutics could also be used in its relative valuation, which is a method of valuing Oncotelic Therapeutics by comparing valuation metrics of similar companies.Oncotelic Therapeutics is currently under evaluation in net income category among its peers.
Oncotelic Fundamentals
| Return On Equity | 0.5 | ||||
| Return On Asset | -0.13 | ||||
| Current Valuation | 31.34 M | ||||
| Shares Outstanding | 391.11 M | ||||
| Shares Owned By Insiders | 55.93 % | ||||
| Number Of Shares Shorted | 662.75 K | ||||
| Price To Earning | 2.16 X | ||||
| Price To Book | 0.89 X | ||||
| Price To Sales | 8.40 X | ||||
| Gross Profit | 1.74 M | ||||
| EBITDA | (8.45 M) | ||||
| Net Income | (9.39 M) | ||||
| Cash And Equivalents | 399.77 K | ||||
| Total Debt | 9.8 M | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 0.03 X | ||||
| Book Value Per Share | 0.06 X | ||||
| Cash Flow From Operations | (4.43 M) | ||||
| Short Ratio | 8.04 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.19 | ||||
| Market Capitalization | 23.9 M | ||||
| Total Asset | 23.61 M | ||||
| Z Score | 1.2 | ||||
| Net Asset | 23.61 M |
About Oncotelic Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oncotelic Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncotelic Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncotelic Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Oncotelic OTC Stock
If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |